885 Characterization of the tumor microenvironment in advanced breast cancer patients treated with talazoparib followed by combination of talazoparib and avelumab

類似資料

• Radiosynthesis and Evaluation of Talazoparib and Its Derivatives as PARP-1-Targeting Agents
  著者:: Dong Zhou, 等
  出版事項: (2021-05-01)
• Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.
  著者:: Florian Schwarz, 等
  出版事項: (2022-01-01)
• Sustained delivery of PARP inhibitor Talazoparib for the treatment of BRCA-deficient ovarian cancer
  著者:: Shicheng Yang, 等
  出版事項: (2023-05-01)
• Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany.
  著者:: Florian Schwarz, 等
  出版事項: (2024-01-01)
• Correction: Cost-effectiveness of talazoparib for patients with locally advanced or metastasized breast cancer in Germany
  出版事項: (2024-01-01)